Navigation Links
Mike Huckabee Accepts Values Voter Presidential Debate

LITTLE ROCK, Ark., Feb. 27 /PRNewswire-USNewswire/ -- Former Arkansas Governor and Presidential Candidate Mike Huckabee accepted an invitation to participate in a Values Voter Presidential Debate to be held on Monday, March 3, 2008. Huckabee received the invitation on Wednesday, February 27, for the debate which would also include Senator John McCain and Congressman Ron Paul.

"I look forward to discussing the issues that are important to the people of America such as health care, education, energy independence, terrorism and national security," Huckabee wrote in his letter of acceptance. "I will clear my schedule to make time for this important debate, provided Sen. McCain participates, otherwise we will keep our current campaign schedule."

On Tuesday, Huckabee challenged Sen. McCain to a Lincoln-Douglas Style debate, but has yet to receive an acceptance from Sen. McCain.

The Values Voter debate is scheduled to be held at the Marriott Riverwalk, 711 E. Riverwalk St. in San Antonio, Tex.

SOURCE Huckabee for President, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AIDS Action Calls on Huckabee to Follow HIV/AIDS Science
2. Huckabees Defense of Earlier, Alarmist AIDS Stance Shows Unsuitability for Presidency, Says AHF
3. New Hampshire AIDS Group Calls on Huckabee to Disavow His 1992 Statement
4. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
7. American Stock Exchange Accepts Encisions Plan to Regain Compliance
8. Governor Rendell Accepts National Health Care Reform Pioneer Award
9. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
10. Lieutenant Governor Catherine Baker Knoll Accepts Women in Government Presidential Leadership Award
11. ev3 Inc. Accepts Resignation of Dr. John Simpson
Post Your Comments:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: